Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
暂无分享,去创建一个
Michael Golatta | Barbara Burwinkel | Manuela Zucknick | Andreas Schneeweiss | Sarah Schott | Christof Sohn | Peter Sinn | Hans Junkermann | Dharanija Madhavan | A. Schneeweiss | M. Golatta | H. Junkermann | C. Sohn | F. Marmé | B. Burwinkel | Dharanija Madhavan | K. Ćuk | A. Turchinovich | P. Sinn | M. Zucknick | S. Schott | Andrey Turchinovich | Katarina Cuk | Jörg Heil | J. Heil | Frederik Marmé | Katarina Ćuk
[1] S Shapiro,et al. Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.
[2] Y. Shu,et al. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis , 2011, Journal of Cancer Research and Clinical Oncology.
[3] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[4] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] Lijuan Guo,et al. Decreased serum miR-181a is a potential new tool for breast cancer screening. , 2012, International journal of molecular medicine.
[6] Hua Zhao,et al. A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer , 2010, PloS one.
[7] Axel Benner,et al. Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.
[8] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[9] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[10] A. Abdollahi,et al. MicroRNA expression after ionizing radiation in human endothelial cells , 2010, Radiation oncology.
[11] B. Burwinkel,et al. Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.
[12] Brigitte Rack,et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.
[13] Masahiko Kushida,et al. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. , 2011, Toxicology letters.
[14] L. Leoncini,et al. B‐cell differentiation in EBV‐positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA‐altered expression , 2010, International journal of cancer.
[15] C. von Buchwald,et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study , 2011, British Journal of Cancer.
[16] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[17] A. Bleyer,et al. Effect of three decades of screening mammography on breast-cancer incidence. , 2012, The New England journal of medicine.
[18] G. Cammarata,et al. 14q32/miRNA Clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up‐regulation of BCL11a , 2010, American journal of hematology.
[19] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[21] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[22] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[23] David Baltimore,et al. MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.
[24] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[25] Ignace Vergote,et al. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers , 2012, Breast Cancer Research.
[26] L. Yin,et al. miR‐376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma , 2012, FEBS letters.
[27] G. MacGrogan,et al. Central atypical papillomas of the breast: a clinicopathological study of 119 cases , 2003, Virchows Archiv.
[28] Xi Chen,et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.
[29] Sung-Chou Li,et al. Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancer , 2011, International journal of cancer.
[30] Sakari Knuutila,et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status , 2012, Genes, chromosomes & cancer.
[31] Qiong Shao,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.
[32] Jean-Baptiste Cazier,et al. Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.
[33] H. Long,et al. Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549 , 2012, Molecules and cells.
[34] R. Navon,et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor , 2012, Molecular Cancer.
[35] Axel Benner,et al. Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer , 2012, Clinical Cancer Research.
[36] S. Feldman,et al. Malignant Transformation of a Breast Fibroadenoma to Cystosarcoma Phyllodes: Case Report and Review of the Literature , 2005, The American surgeon.
[37] M. Goodheart,et al. Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma. , 2012, Experimental and therapeutic medicine.
[38] S. O'toole,et al. Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53 , 2011, British Journal of Cancer.
[39] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[40] Barbara Burwinkel,et al. Extracellular miRNAs: the mystery of their origin and function. , 2012, Trends in biochemical sciences.
[41] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[42] Zhenfeng Duan,et al. MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.
[43] M. L. Hastings,et al. Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells , 2010, PloS one.
[44] Jiyon Lee,et al. The relationship of mammographic density and age: implications for breast cancer screening. , 2012, AJR. American journal of roentgenology.
[45] M. Kwon,et al. The Risk Factors Influencing between the Early and Late Recurrence in Systemic Recurrent Breast Cancer , 2012, Journal of breast cancer.
[46] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[47] N. Boyd,et al. Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.
[48] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.